Related Experiment Video

Updated: Jun 14, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

RhoGDI signaling provides targets for cancer therapy

Michael A Harding1, Dan Theodorescu

  • 1Department of Urology, University of Virginia, Charlottesville, Virginia, USA. mah2n@virginia.edu

European Journal of Cancer (Oxford, England : 1990)
|March 30, 2010
PubMed

Insights

Rho GDP-Dissociation Inhibitors (RhoGDIs) regulate Rho GTPases and are implicated in cancer progression. Targeting RhoGDI signaling offers potential new cancer therapies, though complications must be considered.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • Rho GDP-Dissociation Inhibitors (RhoGDIs) are key regulators of Rho GTPases.
  • Altered RhoGDI expression is observed in various cancers.
  • RhoGDIs play roles in tumorigenesis and cancer progression.

Purpose of the Study:

  • To illustrate potential cancer therapeutic targets by understanding RhoGDI function.
  • To propose novel therapeutic strategies for RhoGDI signaling intervention.
  • To discuss potential complications of these therapeutic strategies.

Main Methods:

  • Analysis of RhoGDI-mediated signaling.
  • Examination of RhoGDI expression patterns in endothelial cells and specific cancers (pancreatic, breast, bladder).

Main Results:

  • RhoGDI function presents numerous potential therapeutic targets in cancer.
  • Examples from endothelial cells and various cancers highlight RhoGDI roles.
  • Novel therapeutic strategies targeting RhoGDI signaling are proposed.

Conclusions:

  • Understanding RhoGDI function is crucial for identifying cancer therapeutic targets.
  • Targeting RhoGDI signaling presents promising therapeutic avenues.
  • Careful consideration of potential complications is necessary for effective intervention.

More Related Videos

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor07:16

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor

Published on: September 13, 2018

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...